SelectScience®’s Post

Did you know that in 2023 the first GPCR5D-targeted bispecific antibody received approval from the US Food and Drug Administration (FDA) as a fifth-line treatment for #multiplemyeloma? Now you can use this anti-GPCR5D antibody developed by abcam to take your interrogations to the next level of understanding. Let's GOOOO! #GPCR5D #progresshappenstogheter #teamworkmakesthedreamwork

Looking for a modern multiplex panel to optimize your cancer research? The Human Tumor Biomarker Panel from Bio-Techne is coming soon, allowing researchers to analyze 28 critical cancer biomarkers including CA125, PSA Total, and Neuro-specific Enolase using just 50 µL of sample. Read more in the June edition of our free xMAP® Resource Round-Up newsletter, now available in your inbox. Subscribe now to receive monthly xMAP® updates, news, and product offerings: https://hubs.li/Q02FgN5G0 #cancerresearch #xMAP #multiplexing

Curasight to present at HC Andersen Capital, BioStock Life Science Summit 2024, and Økonomisk Ugebrev Investor Conference The presentations will include an update on the business progress made by the company during the first three quarters of 2024 and look ahead at the expected coming news flow. Management will give an overall update on the company’s pipeline based on the proprietary uPAR theranostics platform and focused on diagnosing and treating brain cancer, besides the newly reported phase II data with uTRACE® in brain cancer and the preclinical data using uTREAT® and its impact for the clinical development strategy for the coming year. For full press release: https://lnkd.in/dHQXyv3v #curasight #utrace #utreat #cancer #prostatecancer #braincancer

Curious why researchers decided on the Orbitrap Astral MS or Orbitrap Ascend Tribrid MS for their cancer research projects? Join the webinar below, find out and submit your questions to the speakers ⬇️

I'm excited to share insights from the review article "lncRNAs and Cyclin-Dependent Kinases: Unveiling Their Critical Roles in Cancer Progression." This comprehensive study explores how long non-coding RNAs interact with cyclin-dependent kinases (CDKs) to influence cancer development and progression. By dissecting these molecular interactions, the review highlights potential therapeutic targets and strategies for innovative cancer treatments. A must-read for anyone interested in the future of cancer research. #CancerResearch #lncRNAs #CDKs #MolecularBiology #CancerTherapeutics 🔗https://lnkd.in/gweAG635

Tumor-derived #exosomes play a multifaceted role in preparing the pre-metastatic niche, promoting cancer dissemination, and regulating cancer cell dormancy. In this article, the authors discuss the complex process of metastatic disease and the role of tumor-derived exosomes in facilitating breast cancer metastases. 📝 Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy — Bhatia, et al. Full text is available 👇 https://lnkd.in/dSqYDCTc #medicine #health #research #science

🌟 Customer Success Spotlight 🌟 See how Ada Junquera and the Färkkilä Lab are transforming ovarian cancer research with GeoMx DSP! Their latest findings, now published in Cancer Cell, showcase the power of spatial molecular characterization. With plans to expand into Discovery Multiomics, their work underscores GeoMx DSP’s potential to provide integrated insights into health and disease from precious tissue samples, transforming the way we approach complex cancers like ovarian cancer. Dive into their results now 👉 https://lnkd.in/dbnUjhQg #CancerResearch #OvarianCancer #SpatialMultiomics

Could exosomal chaperones be the key to revolutionizing cancer diagnosis and treatment? Wioletta Baranska-Rybak, Gdański Uniwersytet Medyczny (Medical University of Gdańsk), Poland, addressed this intriguing question at #TargetingEVs2024. Her research showcases the potential of exosomal chaperones as emerging biomarkers for cancer diagnosis, prognosis, and treatment. This innovative approach could lead to earlier detection and more personalized therapeutic strategies, paving the way for advancements in cancer care. #TargetingEVs #mitovesicles #microvesicles #extracellularvesicles #mitochondria #cancerbiomarkers #cancer

The Human Tumor Biomarker Panel from @BioTechne is now available, allowing users to analyze up to 28 critical cancer biomarkers using just 50 µL of sample. The panel includes pivotal targets such as CA125, PSA Total, and Neuro-specific Enolase, marking an impactful advancement in cancer research. Curious to learn more? Read the November edition of the xMAP® Resource Round-Up newsletter, now available in your inbox. Subscribe now for updates on the latest #xMAP research, innovations, and product offerings: https://hubs.li/Q02-2kTT0 #Cancer #CancerResearch #multiplexing #labinnovation

We're very happy to have been selected for funding as part of the #BMBF #DataXperiment within the Decade Against Cancer initiative! Our project aims to integrate data from multi-omics and AI protein structure prediction to map molecular networks and understand their changes during cancer progression. In doing so, we hope to further understand disease mechanisms and discover new drug targets. #oncology #cancer #alphafold #XgegenKrebs #Krebsforschung